Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
11/12/2014
Stemline Reports 3Q14 Financial Results and Provides Corporate Update
11/10/2014
Stemline Therapeutics to Participate in the Barclays Select Series Symposium
10/16/2014
Stemline Initiates SL-401 Trial in First CR AML, Second SL-401 Trial Initiated
Copyright 2014 - Stemline Therapeutics, Inc. All rights reserved
Stemline